Study on the risk signal mining related to romiplostim based on the US Food and Drug Administration Adverse Event Reporting System
Zhou Zhangjiuzhi, Ma Leping, Zhang Wei, Li Zhaoxue
Adverse Drug Reactions Journal . 2023, (3): 165 -171 .  DOI: 10.3760/cma.j.cn114015-20221008-00893